Jacques‐Olivier Bay
- Cancer Research top 2%
-
- Sarcoma Diagnosis and Treatment 2
- Renal cell carcinoma treatment 1
- Oncology top 5%
- CAR-T cell therapy research 2
- Molecular Biology top 10%
- Hematology top 10%
- Acute Myeloid Leukemia Research 1
-
- Biomedical Ethics and Regulation 1
-
- Biomedical and Engineering Education 1
-
- Uterine Myomas and Treatments 1
-
- Childhood Cancer Survivors' Quality of Life 1
- Co-authors
- Christine ChevreauBernard EscudierA PłużańskaAlain RavaudAgnieszka Jagiełło-GruszfeldCezary SzczylikEmilio BajettaSergio Bracarda
- Journals
- British Journal of Haematology (2 papers)Cancer (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- FranceSwitzerlandPoland
In The Last Decade
Jacques‐Olivier Bay
7 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Cancer Research 719
- Pulmonary and Respiratory Medicine 1.5k
- Oncology 751
- Molecular Biology 1.1k
- Hematology 149
Countries citing papers authored by Jacques‐Olivier Bay
This map shows the geographic impact of Jacques‐Olivier Bay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques‐Olivier Bay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques‐Olivier Bay more than expected).
Fields of papers citing papers by Jacques‐Olivier Bay
This network shows the impact of papers produced by Jacques‐Olivier Bay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques‐Olivier Bay. The network helps show where Jacques‐Olivier Bay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacques‐Olivier Bay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 2 | |
| 3 | 2017 | 27 | |
| 4 | 2017 | 34 | |
| 5 | 2012 | 53 | |
| 6 | 2010 | 64 | |
| 7 | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trialbreakdown → | 2007 | 1722 |
| 8 | 2006 | 139 |
About Jacques‐Olivier Bay
Jacques‐Olivier Bay is a scholar working on Geriatrics and Gerontology, Hematology, Oral Surgery, Obstetrics and Gynecology and Genetics, having authored 8 papers that have together received 2.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (2 papers), CAR-T cell therapy research (2 papers), Biomedical Ethics and Regulation (1 paper), Biomedical and Engineering Education (1 paper), Acute Myeloid Leukemia Research (1 paper), Renal cell carcinoma treatment (1 paper), Uterine Myomas and Treatments (1 paper) and Childhood Cancer Survivors' Quality of Life (1 paper). The work is most often cited by research in Cancer Research (719 citations), Pulmonary and Respiratory Medicine (1.5k citations), Oncology (751 citations), Molecular Biology (1.1k citations) and Hematology (149 citations). Jacques‐Olivier Bay has collaborated with scholars based in France, Switzerland and Poland. Frequent co-authors include Christine Chevreau, Bernard Escudier, A Płużańska, Alain Ravaud, Agnieszka Jagiełło-Gruszfeld, Cezary Szczylik, Emilio Bajetta, Sergio Bracarda, P. Koralewski and I. Bodrogi. Their work appears in journals such as British Journal of Haematology, Cancer, International Journal of Cancer, Clinical Nutrition and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.